Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery

Abstract Background Systematic nodal dissection plays a crucial role in improving survival and staging in resectable non-small cell lung cancer (NSCLC) patients but at the cost of increasing the occurrence of recurrent laryngeal nerve injury. Technology should be improved to protect the recurrent la...

Full description

Bibliographic Details
Main Authors: Minhao Yu, Mingjian Ge
Format: Article
Language:English
Published: BMC 2021-03-01
Series:BMC Surgery
Subjects:
Online Access:https://doi.org/10.1186/s12893-021-01179-2
id doaj-ad42ff44e5ea4b7ba722be410b4fc24f
record_format Article
spelling doaj-ad42ff44e5ea4b7ba722be410b4fc24f2021-04-04T11:22:31ZengBMCBMC Surgery1471-24822021-03-012111710.1186/s12893-021-01179-2Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgeryMinhao Yu0Mingjian Ge1Department of Thoracic Surgery, Chengdu BOE HospitalDepartment of Thoracic Surgery, The First Affiliated Hospital of Chongqing Medical UniversityAbstract Background Systematic nodal dissection plays a crucial role in improving survival and staging in resectable non-small cell lung cancer (NSCLC) patients but at the cost of increasing the occurrence of recurrent laryngeal nerve injury. Technology should be improved to protect the recurrent laryngeal nerve (RLN) during surgery. Methods NSCLC patients who underwent video-assisted thoracic surgery (VATS) surgical treatment by the same surgeon at our hospital from January 2016 to December 2017 were included as the research subjects and were divided into an energy-device group and a non-energy-device group. Their procedures included anatomic pulmonary resection, normative N1 dissection, and systemic N2 dissection. Results The rate of metastatically involved recurrent laryngeal nerve lymph nodes (RLNLNs) was 5.19% (39/752). Dissection device, side of primary, FEV1, operative time and BMI were independent predictors of recurrent laryngeal nerve injury (RLNI) (hazard ratio (HR) = 3.576, 95% confidence interval (CI): 1.490–8.583, P = 0.004; HR = 0.175, 95% CI: 0.072–0.424, P =  < 0.001; HR = 3.008, 95% CI: 1.30–6.927, P = 0.010; HR = 0.328, 95% CI: 0.136–0.794, P = 0.013; HR = 0.344, 95%CI: 0.147–0.801, P = 0.013, respectively). Patients in the non-energy-device group had significantly less RLNI than the energy-device group (P = 0.016) and nearly half of the non-thermal RLNI recovered in 2 weeks (P = 0.025) whereas most thermal RLNI required 3 months for recovery. Conclusions Every station of RLNLN had some degree of cancer metastasis in NSCLC patients and when dissecting RLNLNs, dissection device was an independent and artificially controlled predictor of RLNI. Using a non-energy device is a feasible method to protect the RLN as well as an improved recovery time of RLNI.https://doi.org/10.1186/s12893-021-01179-2Non-small cell lung cancerRecurrent laryngeal nerve injuryNon-energy deviceSystematic nodal dissection
collection DOAJ
language English
format Article
sources DOAJ
author Minhao Yu
Mingjian Ge
spellingShingle Minhao Yu
Mingjian Ge
Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
BMC Surgery
Non-small cell lung cancer
Recurrent laryngeal nerve injury
Non-energy device
Systematic nodal dissection
author_facet Minhao Yu
Mingjian Ge
author_sort Minhao Yu
title Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
title_short Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
title_full Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
title_fullStr Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
title_full_unstemmed Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
title_sort non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery
publisher BMC
series BMC Surgery
issn 1471-2482
publishDate 2021-03-01
description Abstract Background Systematic nodal dissection plays a crucial role in improving survival and staging in resectable non-small cell lung cancer (NSCLC) patients but at the cost of increasing the occurrence of recurrent laryngeal nerve injury. Technology should be improved to protect the recurrent laryngeal nerve (RLN) during surgery. Methods NSCLC patients who underwent video-assisted thoracic surgery (VATS) surgical treatment by the same surgeon at our hospital from January 2016 to December 2017 were included as the research subjects and were divided into an energy-device group and a non-energy-device group. Their procedures included anatomic pulmonary resection, normative N1 dissection, and systemic N2 dissection. Results The rate of metastatically involved recurrent laryngeal nerve lymph nodes (RLNLNs) was 5.19% (39/752). Dissection device, side of primary, FEV1, operative time and BMI were independent predictors of recurrent laryngeal nerve injury (RLNI) (hazard ratio (HR) = 3.576, 95% confidence interval (CI): 1.490–8.583, P = 0.004; HR = 0.175, 95% CI: 0.072–0.424, P =  < 0.001; HR = 3.008, 95% CI: 1.30–6.927, P = 0.010; HR = 0.328, 95% CI: 0.136–0.794, P = 0.013; HR = 0.344, 95%CI: 0.147–0.801, P = 0.013, respectively). Patients in the non-energy-device group had significantly less RLNI than the energy-device group (P = 0.016) and nearly half of the non-thermal RLNI recovered in 2 weeks (P = 0.025) whereas most thermal RLNI required 3 months for recovery. Conclusions Every station of RLNLN had some degree of cancer metastasis in NSCLC patients and when dissecting RLNLNs, dissection device was an independent and artificially controlled predictor of RLNI. Using a non-energy device is a feasible method to protect the RLN as well as an improved recovery time of RLNI.
topic Non-small cell lung cancer
Recurrent laryngeal nerve injury
Non-energy device
Systematic nodal dissection
url https://doi.org/10.1186/s12893-021-01179-2
work_keys_str_mv AT minhaoyu nonenergydevicestodissectrecurrentlaryngealnervelymphnodesofnonsmallcelllungcancerundervideoassistedthoracicsurgery
AT mingjiange nonenergydevicestodissectrecurrentlaryngealnervelymphnodesofnonsmallcelllungcancerundervideoassistedthoracicsurgery
_version_ 1721542769232576512